SandboxAQ Advances Physics-Informed AI for Bedside Cardiac Diagnostics

According to a recent LinkedIn post from SandboxAQ, the company is highlighting work by its AQMed team to apply physics-informed AI to magnetocardiography for bedside cardiac diagnostics. The content centers on using machine learning to extract clinically relevant signals from faint magnetic fields produced by the heart in standard hospital environments.

The post describes a product effort, CardiAQ, which is positioned as differing from traditional MCG systems that rely on cryogenics, magnetic shielding, and specialized rooms. By emphasizing portability and real-world deployment, the post suggests an ambition to reduce infrastructure needs and potentially broaden access to advanced cardiac risk detection.

According to the video description, the technology aims to make cardiac diagnosis more accurate and more easily performed at the patient’s bedside, including identifying hidden arterial blockages. If clinically validated and adopted, such capabilities could open revenue opportunities across hospitals and clinics seeking faster, non-invasive cardiac assessments.

The post also recounts an example in which MCG helped identify a serious arterial blockage in a real patient, underscoring the potential clinical utility of the approach. For investors, this may indicate SandboxAQ’s strategy to build evidence of efficacy that could support future commercialization, regulatory engagement, and partnerships with healthcare providers or device makers.

Recruitment messaging in the post, including a link to open roles, signals continued investment in technical talent at the intersection of physics, AI, and healthcare. Sustained hiring in this area could point to medium-term R&D spending, but also to a growing pipeline of health-care focused products that may diversify SandboxAQ’s revenue prospects over time.